Market Closed -
Hong Kong S.E.
04:08:13 2024-07-10 am EDT
|
5-day change
|
1st Jan Change
|
7.74
HKD
|
+0.65%
|
|
-2.40%
|
-40.64%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,621
|
5,196
|
-
|
-
|
Enterprise Value (EV)
1 |
7,757
|
4,088
|
4,097
|
3,825
|
P/E ratio
|
38.2
x
|
14.1
x
|
11
x
|
9.1
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.61
x
|
1.47
x
|
1.24
x
|
1.04
x
|
EV / Revenue
|
2.35
x
|
1.16
x
|
0.97
x
|
0.76
x
|
EV / EBITDA
|
11.1
x
|
5.44
x
|
4.61
x
|
3.64
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
5.05
x
|
2.51
x
|
2.06
x
|
1.68
x
|
Nbr of stocks (in thousands)
|
727,355
|
725,743
|
-
|
-
|
Reference price
2 |
11.85
|
7.159
|
7.159
|
7.159
|
Announcement Date
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
3,298
|
3,532
|
4,205
|
5,004
|
EBITDA
1 |
-
|
701.9
|
751.6
|
888.6
|
1,050
|
EBIT
1 |
-
|
534.4
|
589.5
|
726
|
883.5
|
Operating Margin
|
-
|
16.21%
|
16.69%
|
17.26%
|
17.66%
|
Earnings before Tax (EBT)
1 |
-
|
349.4
|
543.4
|
698.7
|
890.5
|
Net income
1 |
680.8
|
234.9
|
380.3
|
490
|
596.8
|
Net margin
|
-
|
7.12%
|
10.77%
|
11.65%
|
11.93%
|
EPS
2 |
0.9600
|
0.3100
|
0.5074
|
0.6488
|
0.7868
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/19/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
864
|
1,108
|
1,098
|
1,371
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
21.2%
|
20.2%
|
20.3%
|
20.4%
|
ROA (Net income/ Total Assets)
|
-
|
4.99%
|
7.7%
|
8.93%
|
9.9%
|
Assets
1 |
-
|
4,704
|
4,939
|
5,488
|
6,027
|
Book Value Per Share
2 |
-
|
2.350
|
2.850
|
3.480
|
4.250
|
Cash Flow per Share
2 |
-
|
0.5300
|
0.6900
|
0.9200
|
1.130
|
Capex
1 |
-
|
149
|
311
|
405
|
387
|
Capex / Sales
|
-
|
4.53%
|
8.8%
|
9.62%
|
7.74%
|
Announcement Date
|
6/19/23
|
3/28/24
|
-
|
-
|
-
|
Last Close Price
7.159
CNY Average target price
13.66
CNY Spread / Average Target +90.77% Consensus |
1st Jan change
|
Capi.
|
---|
| -40.64% | 714M | | -19.48% | 8.38B | | +63.04% | 4.19B | | +14.39% | 2.91B | | -2.80% | 2.63B | | -17.18% | 1.71B | | -60.03% | 1.6B | | -14.25% | 1.55B | | +22.03% | 1.26B | | -50.73% | 999M |
Medical & Diagnostic Laboratories
|